Zeke Capital Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 6,972 shares of VRTX stock, worth $3.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,972

Previous 7,534 7.46%

Holding current value

$3.5 Million

Previous $2.18 Million 7.7%

% of portfolio

0.13%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $160,597 - $180,671	-562 Reduced 7.46%	6,972 $2.01 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1,369 - $1,527	5 Added 0.07%	7,534 $2.18 Million
Q2 2022 Aug 09, 2022	SELL	$234.96 - $292.55 $289,705 - $360,714	-1,233 Reduced 14.07%	7,529 $2.12 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $292,717 - $345,002	1,322 Added 17.77%	8,762 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $49,385 - $62,342	279 Added 3.9%	7,440 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $1.3 Million - $1.45 Million	7,161 New	7,161 $1.3 Million
Q1 2020 Apr 24, 2020	SELL	$199.77 - $247.81 $435,298 - $539,977	-2,179 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$166.71 - $223.91 $2,167 - $2,910	-13 Reduced 0.59%	2,179 $477,000
Q3 2019 Oct 18, 2019	SELL	$166.23 - $187.09 $201,138 - $226,378	-1,210 Reduced 35.57%	2,192 $371,000
Q2 2019 Jul 24, 2019	SELL	$164.61 - $190.37 $3,950 - $4,568	-24 Reduced 0.7%	3,402 $624,000
Q1 2019 Apr 29, 2019	BUY	$163.73 - $194.7 $1,146 - $1,362	7 Added 0.2%	3,426 $630,000
Q4 2018 Feb 11, 2019	SELL	$151.91 - $192.21 $20,052 - $25,371	-132 Reduced 3.72%	3,419 $567,000
Q3 2018 Nov 08, 2018	SELL	$167.73 - $192.74 $158,672 - $182,332	-946 Reduced 21.04%	3,551 $684,000
Q2 2018 Jul 24, 2018	SELL	$145.72 - $169.96 $7,723 - $9,007	-53 Reduced 1.16%	4,497 $764,000
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $343,980 - $401,907	2,269 Added 99.47%	4,550 $742,000
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $98,841 - $111,996	-720 Reduced 23.99%	2,281 $342,000
Q3 2017 Nov 09, 2017	BUY	$148.13 - $162.24 $444,538 - $486,882	3,001	3,001 $456,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Vertex Pharmaceuticals Inc Transaction History